Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Edelman

Showing results (61-70 of 186) with videos related to

Pageof 19
Sort By:
Cancer Genomics & Proteomics|September 20, 2007
Cancer stem cells and individualized therapySaranya Chumsri, Pornima Phatak, Martin J Edelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Targeted radiopharmaceutical therapy for advanced lung cancer: phase I trial of rhenium Re188 P2045, a somatostatin analogMartin J Edelman, Gerry Clamon, Daniel Kahn, et al.
Cancer Investigation|March 20, 2003
Phase I trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignanciesEdith A Perez, David R Gandara, Martin J Edelman, et al.
Medical Care|March 19, 2014
Validation of disability status, a claims-based measure of functional status for cancer treatment and outcomes studiesAmy J Davidoff, Lisa D Gardner, Ilene H Zuckerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2013
Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapyJun Zhao, Mark Z Ma, Hening Ren, et al.
Nursing Research|December 13, 2018
Differential Gene Expression in Erlotinib-Treated FibroblastsKaren E Wickersham, Theresa K Hodges, Martin J Edelman, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2016
Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumorsMartin J Edelman, Rena Lapidus, Josephine Feliciano, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2010
A novel, broad-spectrum anticancer compound containing the imidazo[4,5-e][1,3]diazepine ring systemMin Xie, Ravi K Ujjinamatada, Mariola Sadowska, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2016
Erratum to: Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumorsMartin J Edelman, Rena Lapidus, Josephine Feliciano, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancerMartin J Edelman, David R Gandara, Petr Hausner, et al.
Pageof 19

Showing results (61-70 of 186) with videos related to

Sort By:
Pageof 19
Cancer Genomics & Proteomics|September 20, 2007
Cancer stem cells and individualized therapySaranya Chumsri, Pornima Phatak, Martin J Edelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Targeted radiopharmaceutical therapy for advanced lung cancer: phase I trial of rhenium Re188 P2045, a somatostatin analogMartin J Edelman, Gerry Clamon, Daniel Kahn, et al.
Cancer Investigation|March 20, 2003
Phase I trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignanciesEdith A Perez, David R Gandara, Martin J Edelman, et al.
Medical Care|March 19, 2014
Validation of disability status, a claims-based measure of functional status for cancer treatment and outcomes studiesAmy J Davidoff, Lisa D Gardner, Ilene H Zuckerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2013
Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapyJun Zhao, Mark Z Ma, Hening Ren, et al.
Nursing Research|December 13, 2018
Differential Gene Expression in Erlotinib-Treated FibroblastsKaren E Wickersham, Theresa K Hodges, Martin J Edelman, et al.
Cancer Chemotherapy and Pharmacology|September 14, 2016
Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumorsMartin J Edelman, Rena Lapidus, Josephine Feliciano, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2010
A novel, broad-spectrum anticancer compound containing the imidazo[4,5-e][1,3]diazepine ring systemMin Xie, Ravi K Ujjinamatada, Mariola Sadowska, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2016
Erratum to: Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumorsMartin J Edelman, Rena Lapidus, Josephine Feliciano, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancerMartin J Edelman, David R Gandara, Petr Hausner, et al.
Pageof 19